Bio-Rad Labs (BIO) Tops Q1 EPS by 55c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $294.25 +0.22%
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.65, $0.55 better than the analyst estimate of $1.10. Revenue for the quarter came in at $554 million versus the consensus estimate of $549.56 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Belden completes acquisition of Ruckus Networks from Vistance
- PPHC acquires London firm Tancredi for up to £25 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
